Uniquement disponible en Anglais (US)
|
ECLIPSE 5
{{ getTitle(live) }}
{{ toDate(live.liveStartDate) }}
{{ toTime(live.liveStartDate) }} - {{ toTime(live.liveEndDate) }}
{{ getNotification(live) }}
To EDUCATE lung cancer treaters to expand their knowledge on the use of the dual immunotherapy nivolumab + ipilimumab in cancer patients based on patient case presentations in an international live virtual pan-tumor ‘meet the expert’ setting.
Missed the previous ECLIPSE editions and want to watch (parts of) the meeting again? Check out the recordings by clicking here!
| Welcome & Introduction |
| Dr. Paul Lacante (BMS Medical Director) |
| Dual immunotherapy: Experience in MPM |
| Prof. Dr. Arnaud Scherpereel |
| Dual immunotherapy: Experience in NSCLC |
| Prof. Dr. Martin Reck |
| Meet the Expert: Panel discussion |
| Meeting close |
Experts
Prof. Dr. Arnaud Scherpereel
Dept of Pulmonary & Thoracic Oncology, University Hospital (CHU) Lille, France
Prof. Dr. Martin Reck
Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Germany
| Welcome & Introduction |
| Dr. Paul Lacante (BMS Medical Director) |
| Dual immunotherapy: Experience in MPM |
| Prof. Dr. Arnaud Scherpereel |
| Dual immunotherapy: Experience in NSCLC |
| Prof. Dr. Martin Reck |
| Meet the Expert: Panel discussion |
| Meeting close |